Results 261 to 270 of about 720,989 (310)
Some of the next articles are maybe not open access.
Medical Physics, 1993
Dosimetry data arising from a decade of radioimmunotherapy are summarized along with techniques utilized to arrive at the reported dose estimates. Generality of the MIRD methodology allows it to serve as a vehicle for the calculation of solid tumor dosimetry although several limitations exist.
R F, Meredith +7 more
openaire +2 more sources
Dosimetry data arising from a decade of radioimmunotherapy are summarized along with techniques utilized to arrive at the reported dose estimates. Generality of the MIRD methodology allows it to serve as a vehicle for the calculation of solid tumor dosimetry although several limitations exist.
R F, Meredith +7 more
openaire +2 more sources
Tumor Mutational Burden Testing in Solid Tumors
JAMA Oncology, 2023A 58-year-old man with diabetes, chronic kidney disease, and JAK2-positive myeloproliferative neoplasm is referred for newly diagnosed oligometastatic prostate cancer with substantial urinary symptoms. What would you do next?
Regina, Kwon +2 more
openaire +2 more sources
Cancer Chemotherapy and Pharmacology, 2012
Lenalidomide is a thalidomide analogue with immunomodulatory and anti-angiogenic properties that include altering cytokine production, activating T cells, and augmenting natural killer cell function. Lenalidomide is approved by the U.S. Food and Drug Administration (FDA) for single-agent treatment of myelodysplastic syndromes associated with a 5q ...
Angela, Segler +1 more
openaire +2 more sources
Lenalidomide is a thalidomide analogue with immunomodulatory and anti-angiogenic properties that include altering cytokine production, activating T cells, and augmenting natural killer cell function. Lenalidomide is approved by the U.S. Food and Drug Administration (FDA) for single-agent treatment of myelodysplastic syndromes associated with a 5q ...
Angela, Segler +1 more
openaire +2 more sources
Nursing Clinics of North America, 1994
A thorough understanding of the incidence, clinical presentation, treatment, prognosis, and psychosocial issues surrounding children with solid tumors enables the nurse to actively participate on the health care team. Although significant advances over the past two-and-a-half decades to improve the outcomes of children with cancer have occurred, there ...
J, Nemes, M C, Donahue
openaire +2 more sources
A thorough understanding of the incidence, clinical presentation, treatment, prognosis, and psychosocial issues surrounding children with solid tumors enables the nurse to actively participate on the health care team. Although significant advances over the past two-and-a-half decades to improve the outcomes of children with cancer have occurred, there ...
J, Nemes, M C, Donahue
openaire +2 more sources
The Indian Journal of Pediatrics, 2004
Cancer is one of the leading causes of death in children. There is the need to have the histologic review of malignancies in children from the Indian sub-continent.In the present study, malignant tumors received over 12 years were reviewed and re-classified according to classifications based on prognosis.A total of 472 tumors were received over 12 ...
Sonal, Sharma +3 more
openaire +2 more sources
Cancer is one of the leading causes of death in children. There is the need to have the histologic review of malignancies in children from the Indian sub-continent.In the present study, malignant tumors received over 12 years were reviewed and re-classified according to classifications based on prognosis.A total of 472 tumors were received over 12 ...
Sonal, Sharma +3 more
openaire +2 more sources
Unusual Solid Pancreatic Tumors
Radiologic Clinics of North America, 2012The vast array of possible histologies for a given pancreatic mass makes the specific diagnosis of a solid pancreatic mass in an individual patient challenging. This article discusses and reviews the imaging findings of those entities that are likely to be encountered in clinical practice, specifically pancreatic endocrine tumors, solid pseudopapillary
openaire +2 more sources
Postgraduate Medicine, 1970
In the majority of solid malignant tumors, chemotherapy and hormonal therapy are only palliative. Nonetheless, drugs or hormones can bring worthwhile subjective and objective improvement. Every patient with a recurrent malignant process should be considered for chemotherapy, but strict guidelines must be followed in selection of patients.
openaire +2 more sources
In the majority of solid malignant tumors, chemotherapy and hormonal therapy are only palliative. Nonetheless, drugs or hormones can bring worthwhile subjective and objective improvement. Every patient with a recurrent malignant process should be considered for chemotherapy, but strict guidelines must be followed in selection of patients.
openaire +2 more sources
Journal of Pediatric Nursing, 2003
Solid tumors make up about 30% of all pediatric cancers. The most common types of solid tumors in children include brain tumors, neuroblastoma, rhabdomyosarcoma, Wilms' tumor, and osteosarcoma. This article reviews the etiology and treatment of these diseases, and discusses the differences between adult and pediatric solid tumors.
Nancy E, Kline, Nicole, Sevier
openaire +2 more sources
Solid tumors make up about 30% of all pediatric cancers. The most common types of solid tumors in children include brain tumors, neuroblastoma, rhabdomyosarcoma, Wilms' tumor, and osteosarcoma. This article reviews the etiology and treatment of these diseases, and discusses the differences between adult and pediatric solid tumors.
Nancy E, Kline, Nicole, Sevier
openaire +2 more sources
Virchows Archiv B Cell Pathology, 1978
Systematic chromosomal studies in solid tumors have been scanty (excepting meningiomas), because of the fact that it is difficult to obtain tumor material at desired times and only in about 10--15% of the cases adequate chromosome preparations are suitable with a direct technique or short term culture.
S, Kakati, A A, Sandberg
openaire +2 more sources
Systematic chromosomal studies in solid tumors have been scanty (excepting meningiomas), because of the fact that it is difficult to obtain tumor material at desired times and only in about 10--15% of the cases adequate chromosome preparations are suitable with a direct technique or short term culture.
S, Kakati, A A, Sandberg
openaire +2 more sources
Expert Opinion on Investigational Drugs, 2010
Dasatinib is an oral, potent adenosine triphosphate-competitive inhibitor of multiple tyrosine kinases including BCR-ABL, c-KIT, platelet-derived growth factor receptor, and Src family kinases (SFKs). It has gained much attention for its use in chronic myeloid leukemia and for the treatment of adults with Philadelphia chromosome-positive acute ...
Lori C, Kim, Uwe, Rix, Eric B, Haura
openaire +2 more sources
Dasatinib is an oral, potent adenosine triphosphate-competitive inhibitor of multiple tyrosine kinases including BCR-ABL, c-KIT, platelet-derived growth factor receptor, and Src family kinases (SFKs). It has gained much attention for its use in chronic myeloid leukemia and for the treatment of adults with Philadelphia chromosome-positive acute ...
Lori C, Kim, Uwe, Rix, Eric B, Haura
openaire +2 more sources